Evidence map›Paper›PMID 34069689›Full record

ArticleCancers2021

Multimodal Imaging Techniques to Evaluate the Anticancer Effect of Cold Atmospheric Pressure Plasma.

Marcel Kordt, Isabell Trautmann, Christin Schlie, Tobias Lindner, Jan Stenzel, Anna Schildt, Lars Boeckmann, Sander Bekeschus, Jens Kurth, Bernd J Krause and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Marcel KordtRudolf-Zenker-Institute of Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0002-5826-1217
Isabell TrautmannRudolf-Zenker-Institute of Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany.
Christin SchlieRudolf-Zenker-Institute of Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany.
Tobias LindnerCore Facility Multimodal Small Animal Imaging, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0001-7826-3132
Jan StenzelCore Facility Multimodal Small Animal Imaging, Rostock University Medical Center, 18057 Rostock, Germany.
Anna SchildtCore Facility Multimodal Small Animal Imaging, Rostock University Medical Center, 18057 Rostock, Germany.
Lars BoeckmannClinic and Policlinic for Dermatology and Venereology, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0003-0098-6546
Sander BekeschusCenter for innovation competence (ZIK) plasmatis, Leibniz Institute for Plasma Science and Technology (INP), 17489 Greifswald, Germany.ORCID 0000-0002-8773-8862
Jens KurthDepartment of Nuclear Medicine, Rostock University Medical Center, 18055 Rostock, Germany.ORCID 0000-0001-6864-4513
Bernd J KrauseCore Facility Multimodal Small Animal Imaging, Rostock University Medical Center, 18057 Rostock, Germany.
Brigitte VollmarRudolf-Zenker-Institute of Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany.
Eberhard GrambowRudolf-Zenker-Institute of Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0003-1101-3176
University of Rostock · DELeibniz Institute for Plasma Science and Technology · DE

Funding

European Social Fund ESF/14-BM-A55-0001/18European Social Fund ESF/14-BM-A55-0003/18European Social Fund ESF/14-BM-A55-0006/18
6 · The paper itself

Abstract

backgroundSkin cancer is the most frequent cancer worldwide and is divided into non-melanoma skin cancer, including basal cell carcinoma, as well as squamous cell carcinoma (SCC) and malignant melanoma (MM).

methodsThis study evaluates the effects of cold atmospheric pressure plasma (CAP) on SCC and MM in vivo, employing a comprehensive approach using multimodal imaging techniques. Longitudinal MR and PET/CT imaging were performed to determine the anatomic and metabolic tumour volume over three-weeks in vivo. Additionally, the formation of reactive species after CAP treatment was assessed by non-invasive chemiluminescence imaging of L-012. Histological analysis and immunohistochemical staining for Ki-67, ApopTag

resultsAs the main result, multimodal in vivo imaging revealed a substantial reduction in tumour growth and an increase in reactive species after CAP treatment, in comparison to untreated tumours. In contrast, neither the markers for apoptosis, nor the metabolic activity of both tumour entities was affected by CAP.

conclusionsThese findings propose CAP as a potential adjuvant therapy option to established standard therapies of skin cancer.

Indexed as

kINPen™malignant melanomaplasma medicinereactive oxygen and nitrogen speciesskin cancersquamous cell carcinoma

Identifiers

PMID34069689
PMCPMC8161248
OpenAlexW3159985082

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.